US Patent Issued to United Biomedical on July 8 for "Peptide immunogens targeting interleukin 6 (IL-6) and formulations thereof for immunotherapy of diseases impacted by IL-6 dysregulation" (American, Taiwanese Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,350,322, issued on July 8, was assigned to United Biomedical Inc. (Hauppauge, N.Y.).

"Peptide immunogens targeting interleukin 6 (IL-6) and formulations thereof for immunotherapy of diseases impacted by IL-6 dysregulation" was invented by Chang Yi Wang (Cold Spring Harbor, N.Y.), Feng Lin (Hauppauge, N.Y.), Jiun Bo Chen (Taipei, Taiwan) and Shuang Ding (Hauppauge, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to individual peptide immunogen constructs targeting portions of the Interleukin-6 (IL-6) protein, compositions containing the constructs, antibodies elicited by the constructs, and methods for making and usi...